Patient and tumour characteristics and health-related quality of life 3 years after oesophageal cancer surgery (n=172), categorised by educational level
| Education level | ||
| High (≥10 years) No (%) | Low (≤9 years) No (%) | |
| Total | 94 | 78 |
| Gender | ||
| Men | 73 (78) | 63 (81) |
| Women | 21 (22) | 15 (19) |
| Age at surgery (years) | ||
| <60 | 28 (30) | 16 (21) |
| 60–74 | 58 (62) | 50 (15) |
| ≥75 | 8 (9) | 12 (15) |
| No of comorbidities | ||
| 0 | 59 (63) | 35 (45) |
| ≥1 | 35 (37) | 43 (55) |
| Body mass index (kg/m2) | ||
| ≥25 | 54 (57) | 38 (49) |
| <25 | 40 (43) | 40 (51) |
| Tumour histology | ||
| Squamous cell carcinoma | 16 (17) | 23 (29) |
| Adenocarcinoma | 78 (83) | 55 (71) |
| Tumour location | ||
| Upper/middle oesophagus | 9 (10) | 14 (18) |
| Lower oesophagus or cardia | 85 (90) | 64 (82) |
| Pathological tumour stage | ||
| 0–I | 44 (47) | 26 (33) |
| II | 25 (27) | 31 (40) |
| III | 21 (22) | 17 (22) |
| IV | 4 (4) | 4 (5) |
| Neoadjuvant therapy | ||
| No | 91 (97) | 77 (99) |
| Yes | 3 (3) | 1 (1) |
| Surgical approach | ||
| Transthoracic | 72 (77) | 66 (85) |
| Transhiatal | 22 (23) | 12 (15) |
| Postoperative complications | ||
| No | 62 (66) | 50 (64) |
| Yes | 32 (34) | 28 (36) |